Figure 2
From: Identification of metabolites with anticancer properties by computational metabolomics
Effect of endogenous metabolites on the proliferation of Jurkat cells. The percentage of surviving cells is given as a percentage of the number of control cells after 72 h of incubation in the presence of the tested metabolite at a concentration of 100 μmol/L. Effect of metabolites predicted to be lowered (A), increased (B) or unchanged (C) in Jurkat cells when compared with normal lymphoblasts, on the proliferation of Jurkat cells (2 biological replicates, each with 4 analytical replicates). MQ = menaquinone; HS = α-hydroxystearic acid; DE = dehydroepiandrosterone; SU = 3-sulfino-L-alanine; DM = 5,6-dimethylbenzimidazole; SE = seleno-L-methionine; RB = riboflavin; TN = tryptamine; HA = hydroxyacetone; BR = bilirubin; AT = androsterone; HV = homovanillic acid; VA = vanillylmandelic acid; AA = N-acetyl-L-aspartate; TA = taurocholic acid, CA = citric acid; PA = pantothenic acid; GA = β-D-galactose; FA = folic acid; CH = cholesterol. Error bars represent standard error of mean.